Skip to NavigationSkip to content

Cascade Chemistry begins $14m manufacturing facility expansion

Published on 19/02/21 at 10:32am
Image credit: Business Wire

Cascade Chemistry, a leading pharmaceutical contract development and manufacturing organisation, has initiated the $14 million construction of new facilities to increase the company’s capacity to manufacture APIs (active pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures).

The company’s new facilities, expected to be operational in the first quarter of next year, will ultimately increase the company’s floor space almost three-fold, and significantly add to its cGMP manufacturing capacity and scale. The expansion also includes 2,200 square feet of new analytical labs, a robust quality system, and additional office space.

The 28,000-square-foot building currently under construction will initially include five suites for Phase I and Phase II cGMP manufacturing, with flow hydrogenation and reactors up to 400 litres. Additional capacity for API Phase III and commercial scale cGMP manufacturing up to 1,000 litres will be added in 2022, while a second building of 7,000 square feet is reserved for future expansion.

Dr Jeremiah Marsden, President of Cascade Chemistry, said: “This $14 million expansion reflects our growing success as a reliable, experienced, and flexible outsourcing partner with exceptional chemistry problem-solving expertise.

“Our customers are increasingly requesting our assistance in producing APIs for their clinical trials, and demand has outstripped our cGMP manufacturing capacity. We were fortunate to acquire two suitable buildings just 10 minutes from our current facility, and construction of new cGMP manufacturing suites that will greatly increase our clinical trial API production capacity is now underway.”

Dr Marsden added: “We ultimately will expand into the second new building to build further cGMP capacity for commercial-stage low-volume, high-value pharmaceuticals. We are grateful for the support from our customers that is driving this expansion, as well as our employees’ dedication to excellence and their creativity and hard work that make it all possible.”

Darcy Jimenez

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches